NEW YORK (GenomeWeb) – Horizon Discovery Group and Abcam today announced a licensing and supply agreement that gives Abcam exclusive access to more than 1,800 human diploid and haploid cell lines from Horizon's X-MAN collection. 

The cell lines will help in the validation of Abcam's existing monoclonal and polyclonal antibodies marketed to researchers, the firms said, and Horizon will develop additional haploid cell lines to validate new antibodies from Abcam. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.